abs67.txt	importance		localized	prostate	cancer	diagnosis	and	treatment	among	elderly	menwho	are	not	likely	to	benefit	represents	a	potential	source	of	low-value	healthcare	services	objective	quantify	the	costs	medicare	program	associated	withdetection	men	in	unitedstates	design	setting	participants	this	nationwide	population-based	retrospective	cohort	study	uses	surveillance	epidemiology	end	results(seer)-medicare	linked	database	identify	70	years	or	older	diagnosed	withlocalized	between	2004	2007	ascertain	costsassociated	with	workup	follow-up	morbiditymanagement	disease	national	were	estimated	usingper-person	stage-adjusted	incidence	rates	by	age	from	seer2007	through	2011	2010	census	population	estimates	main	outcomes	measures	overall	andin	each	(mutually	exclusive)	category	related	morbidity	management	results	included49	692	nonmetastatic	seer-medicare	database(all	25	981	[52	3%]	76	older)	median	per-patient	cost	within	3	after	was$14	453	(interquartile	range	[iqr]	$4887-$27	899)	majority	wasattributable	(median	$10	558	iqr	$1990-$23	718)	patientswith	gleason	score	6	lower	who	pursued	initial	conservative	management(no	12	months	diagnosis)	had	3-year	total	of$1914	per	patient	programassociated	annual	detection	olderis	approximately	$1	2	billion	increasing	active	use	those	withgleason	could	reduce	$320	million	conclusions	relevance	there	is	substantial	amongelderly	united	states	despite	fact	that	these	unlikely	todie	reducingprovision	health	care	couldresult	significant	savings
